Exclusive: Sanofi stops enrolling COVID-19 patients in hydroxychloroquine trials amid safety concerns
* EXCLUSIVE - SANOFI SAYS SUSPENDS RECRUITMENT OF NEW PATIENTS IN CO'S 2 HYDROXYCHLOROQUINE COVID-19 CLINICAL TRIALS @reuters
Sanofi says ‘no favoritism’ when COVID-19 vaccines become available via @rapplerdotcom
Sanofi brings in 4 new executives in continued shake-up, as vaccines and consumer health chief head out the door $SNY @jasonmast5
People of all races, religions and nationalities work at Sanofi every day to improve the lives of people around the world. While all pharmaceutical treatments have side effects, racism is not a known side effect of any Sanofi medication.
Strange that the New York Times would fail to mention this publicly disclosed information🙄 Instead they try to make it seem like he was self dealing because he was hopeful! Trump’s personal stake in the malaria-drug maker Sanofi could be as small as $99
We regret to inform you that the NYT article on Trump's 'small personal financial interest' in Sanofi is total BS
BREAKING: Sanofi is trialing anti-malaria medications against coronavirus and says trials are promising